Two medications have been shown to drastically alter the prognosis for the fatal...
Terns Pharmaceuticals’ decision to move away from the liver disease field may tu...
Relay Therapeutics released interim Phase I/II data showing that RLY-2608, its i...
Viridian announced that veligrotug, its potential thyroid eye disease (TED) drug...
Brightflow SAS, a privately owned company at the forefront in the area of long-t...
Genesis Therapeutics’ AI drug discovery platform, GEMS, has gained popularity an...
Eli Lilly’s insulin candidate efsitora alfa has achieved its main goals in a fur...
After successfully completing two trials, SWIFT-1 and SWIFT-2, for its long-acti...
Onward Medical revealed that it has received a major grant from the Christopher ...
In a decision expected to limit Brussels’ merger authority, American gene sequen...
Sanofi has announced that tolebrutinib, a BTK inhibitor, failed in two out of th...
Athira Pharma’s Phase 2/3 Alzheimer’s disease trial has ended in failure. The tr...
Shanghai Allist Pharmaceuticals has significantly bolstered its position in Chin...
Emergent BioSolutions’ smallpox vaccine has received expanded approval from the ...
As part of its strategy to expand PET imaging capabilities, Siemens Healthineers...
Bavarian Nordic announced today that its vaccine, JYNNEOS, has been licensed by ...
